Researchers have spent more than three decades
developing and studying miniature biosensors that can identify
single molecules. In 5 to 10 years, when such devices may become a
staple in doctors’ offices, they could detect molecular markers for
cancer and other diseases and assess the effectiveness of drug
treatment to fight those illnesses.